Nabumetone
Product Images NDC 33358-251

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 33358-251). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxchange Co., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Nabumetone (5276f530 14bc 492d 974b 913fd06bf52e 01)

Chemical structure of Nabumetone (C15H16O2), showing its molecular formula and molecular weight (228.3). The structure includes fused aromatic rings and side chains with functional groups.*

FDA Label Image

6mna (5276f530 14bc 492d 974b 913fd06bf52e 02)

Chemical structure of nabumetone's active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA), showing its molecular arrangement with methoxy and carboxylic acid functional groups on a naphthalene ring system.*

FDA Label Image

Table 1 (5276f530 14bc 492d 974b 913fd06bf52e 03)

A data table presenting pharmacokinetic parameters including Tmax (hours), half-life (t1/2, hours), clearance (CLss/F, mL/min), and volume of distribution (Vdss/F, L) for Nabumetone in three groups: young adults at 1,000 mg and 2,000 mg doses, and elderly adults at a 1,000 mg dose. The table includes mean values with standard deviations and sample sizes.*

FDA Label Image

6mna Plasma Concentrations (5276f530 14bc 492d 974b 913fd06bf52e 04)

Line graph depicting Nabumetone active metabolite (6MNA) plasma concentrations over time in hours following once-daily dosing of 1000 mg and 2000 mg Nabumetone. Concentrations (mcg/mL) are shown with plus and minus two standard deviation ranges for each dose, indicating variability across subjects.*

FDA Label Image

Metabolites (5276f530 14bc 492d 974b 913fd06bf52e 05)

Table presenting the percentage of various metabolites and unchanged forms of nabumetone identified, including nabumetone (not detectable), 6-methoxy-2-naphthylacetic acid (unchanged and conjugated), 6-hydroxy-2-naphthylacetic acid (unchanged and conjugated), 4-(6-hydroxy-2-naphthyl)-butan-2-ol (conjugated), O-desmethyl-nabumetone (conjugated), and unidentified minor metabolites, totaling 73% dose.*

FDA Label Image

Table 2 (5276f530 14bc 492d 974b 913fd06bf52e 06)

A data table showing the number of patients receiving different doses of Nabumetone (500 mg, 1000 mg, 1500 mg, 2000 mg) and the mean or mode duration of treatment in years for osteoarthritis (OA) and rheumatoid arthritis (RA) patient groups.*

FDA Label Image

Side Effects Table (5276f530 14bc 492d 974b 913fd06bf52e 07)

A drug facts text panel listing serious and other side effects of Nabumetone. Serious side effects include heart attack, stroke, high blood pressure, kidney and liver problems, anemia, life-threatening skin and allergic reactions, and asthma attacks. Other side effects include stomach pain, constipation, diarrhea, gas, heartburn, nausea, vomiting, and dizziness.*

FDA Label Image

Get Emergency Help If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 08)

A text panel listing potential symptoms including shortness of breath or trouble breathing, chest pain, weakness in one part or side of the body, slurred speech, and swelling of the face or throat.*

FDA Label Image

Stop Nsaid If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 09)

A text panel listing possible side effects including nausea, tiredness, itching, jaundice, stomach pain, flu-like symptoms, vomiting blood, bloody or tar-like bowel movements, unusual weight gain, skin rash or blisters with fever, and swelling of extremities.*

FDA Label Image

Nsaid Medications That Need A Prescription (5276f530 14bc 492d 974b 913fd06bf52e 10)

A table listing generic drug names alongside their corresponding tradenames. It includes a variety of nonsteroidal anti-inflammatory drugs (NSAIDs) such as Celecoxib (Celebrex), Diclofenac (Cataflam, Voltaren, Arthrotec), Ibuprofen (Motrin, Tab-Profen, Vicoprofen), Nabumetone (Relafen), and others, with some notes on combination products.*

FDA Label Image

Glenmark Logo (5276f530 14bc 492d 974b 913fd06bf52e 11)

FDA Label Image

Rxchange Co. (33358-251-60) Nabumetone 500mg (Rxchange Co. (33358 251 60) Nabumetone 500mg)

Label for Nabumetone 500 mg tablets by RxChange Co., containing 60 tablets. The white film-coated, oval-shaped tablets are embossed with "IG" and "257". The label includes product identification, lot number, expiration date, storage instructions, and manufacturer details (Invagen Pharmaceuticals Inc.).*

FDA Label Image

Rxchange Co. (33358-252-60) Nabumetone 750mg (Rxchange Co. (33358 252 60) Nabumetone 750mg)

Nabumetone 750mg tablet bottle label from RxChange Co. The label indicates 60 tablets in the package, with the product described as beige, film-coated, oval biconvex tablets debossed with 99G99 and 9925899 on different sides. The label includes NDC 33358-252-60, storage instructions, manufacturer INVAGEN Pharmaceuticals, and a warning to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.